Hoedemaker, Niels P G <br/><br/>
Trends in cardiovascular and bleeding outcomes in acute coronary syndrome patients treated with or without proton-pump inhibitors during the introduction of novel P2Y12 inhibitors: a five-year experience from a single-centre observational registry.  [electronic resource] 

 -  European heart journal. Cardiovascular pharmacotherapy  07 2019 
 - 127-138 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study 
<br/><br/><label>ISSN: </label>2055-6845 
<br/><br/><label>Standard No.: </label>10.1093/ehjcvp/pvy030  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Coronary Syndrome--diagnosis<br/>Aged<br/>Drug Prescriptions<br/>Female<br/>Gastrointestinal Hemorrhage--chemically induced<br/>Humans<br/>Male<br/>Middle Aged<br/>Netherlands--epidemiology<br/>Non-ST Elevated Myocardial Infarction--diagnosis<br/>Percutaneous Coronary Intervention--adverse effects<br/>Platelet Aggregation Inhibitors--administration & dosage<br/>Practice Patterns, Physicians'--trends<br/>Proton Pump Inhibitors--administration & dosage<br/>Purinergic P2Y Receptor Antagonists--administration & dosage<br/>Recurrence<br/>Registries<br/>Retrospective Studies<br/>Risk Assessment<br/>Risk Factors<br/>ST Elevation Myocardial Infarction--diagnosis<br/>Stroke--diagnosis<br/>Time Factors<br/>Treatment Outcome